PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights

PMV will host an investor webinar on Wednesday, September 10, 2025 at 8:00 AM ET to review Phase 2 PYNNACLE clinical trial interim analysis     Interim analysis will include data for approximately 65 patients with at least 18 weeks of follow-up   Cash, cash equivalents, and marketable securities of